Price action has taken bullish reversal from core support levels after prolonged downtrend and now, Breakout with volume surge is yet to be seen. Already, the scrip has seen volume increase during past few sessions
Aiming for short term for Target 1 and 2 after breakout from trendline.
The company has shown progressive results in Q2
www.business-standar...-117111000808_1.html
Moreover, Risk:rewards ratio is also fine with Price to book value: 1.74 with company managing to reduce debt
www.screener.in/company/JBCHEPHARM/
Rest in charts..
Aiming for short term for Target 1 and 2 after breakout from trendline.
The company has shown progressive results in Q2
www.business-standar...-117111000808_1.html
Moreover, Risk:rewards ratio is also fine with Price to book value: 1.74 with company managing to reduce debt
www.screener.in/company/JBCHEPHARM/
Rest in charts..